Quest Diagnostics (DGX) vs Mettler-Toledo International (MTD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Quest Diagnostics (DGX) has outperformed Mettler-Toledo International (MTD) over the past year, gaining 24.8% versus a gain of 17.1%. Over five years, DGX leads with a +59.3% price change compared with +8.2% for MTD. Mettler-Toledo International is the larger company by market cap ($30.73 billion vs $25.06 billion), about 1.2 times the size, while Quest Diagnostics is growing revenue faster (+11.8% vs +4.0%).
On valuation, Quest Diagnostics trades at a lower forward P/E (18.8x vs 29.6x for Mettler-Toledo International). Quest Diagnostics pays a dividend yielding 1.46%, while Mettler-Toledo International does not currently pay one. Mettler-Toledo International converts more of its revenue into profit, with a net margin of 21.6% versus 9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DGX | MTD |
|---|---|---|
| Share price | $227.06 | $1,533.48 |
| Market cap | $25.06B | $30.73B |
| 1-day change | -0.58% | +0.03% |
| YTD return | +30.85% | +9.99% |
| 1-year return | +24.83% | +17.14% |
| 5-year return | +59.34% | +8.16% |
| P/E ratio (TTM) | 24.10 | 34.55 |
| Forward P/E | 18.84 | 29.62 |
| EPS (TTM) | $9.42 | $44.38 |
| Dividend yield | 1.46% | 0.00% |
| Annual dividend | $3.32 | $0.00 |
| Revenue (latest FY) | $11.04B | $4.03B |
| Revenue growth (YoY) | +11.78% | +3.98% |
| Net income (latest FY) | $992.00M | $869.19M |
| Gross margin | 33.21% | 59.37% |
| Operating margin | 14.10% | — |
| Net margin | 8.99% | 21.59% |
| 52-week high | $248.84 | $1,585.72 |
| 52-week low | $171.18 | $1,023.05 |
| Distance from 52-week high | -8.75% | -3.29% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +9.25% | -4.04% |
| Average volume | 1.04M | 183.40K |
| Shares outstanding | 110.37M | 20.04M |
| Employees | 46,000 | 16,600 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Mettler-Toledo International trades at a higher earnings multiple (34.6x vs 24.1x trailing P/E).
- Quest Diagnostics offers a meaningfully higher dividend yield (1.46% vs 0.00%).
- Mettler-Toledo International is more profitable, keeping 21.6 cents of every revenue dollar as net income versus 9.0 cents for Quest Diagnostics.
- Quest Diagnostics grew revenue faster in its latest fiscal year (+11.78% vs +3.98%).
- The two companies sit in different sectors: Quest Diagnostics in Health Care and Mettler-Toledo International in Industrials.
About Quest Diagnostics
DGX stock →Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Health Care · Medical Specialities · 46,000 employees
About Mettler-Toledo International
MTD stock →Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees
DGX vs MTD FAQ
Which is bigger, Quest Diagnostics or Mettler-Toledo International?
Mettler-Toledo International (MTD) is larger, with a market capitalization of $30.73B compared with $25.06B for Quest Diagnostics (DGX).
Which stock has performed better over the past year, DGX or MTD?
DGX returned +24.83% over the past 12 months, compared with +17.14% for MTD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DGX or MTD?
DGX has the lower trailing P/E at 24.1, versus 34.6 for MTD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Quest Diagnostics or Mettler-Toledo International?
Quest Diagnostics pays a dividend yielding 1.46%, while Mettler-Toledo International does not currently pay a regular dividend.
Are Quest Diagnostics and Mettler-Toledo International in the same industry?
No. Quest Diagnostics is in the Health Care sector, while Mettler-Toledo International is in Industrials.